ARCHIVES

FDA Approves Afinitor-Aromasin Regimen For Advanced HER2-Negative Breast Cancer

This article is from The Cancer Letter archive.

Vol. 35 No. 7 | July 27, 2012

Download PDF Visit The Full Archive

Related Articles

Funding Opportunities

February 7, 2003

Weight Gain After Diagnosis Increases Risk Of Death

December 28, 2007

AACR Opposes Human Life Bill; ASCO Backs Cancer Act, Reimbursement

May 8, 1981

FDA Approves SNDA For Gardasil For Anal Cancer And Precancerous Lesions

January 28, 2011

Treanda Approved For B-Cell Non-Hodgkin’s Lymphoma

October 31, 2008

NCI Cooperative Group Clinical Trials Approved

October 30, 2009